When a cancer diagnosis arrives, most patients and families instinctively look outward — to hospitals, imaging machines, chemotherapy protocols, and surgical suites. This response is rational. Modern oncology has achieved extraordinary things. But as a professor of Korean Medicine at Dongguk University specializing in pathology and oncology, I have spent decades watching what happens after the protocol ends. What I have observed consistently is this: the patients who recover well are not always those who received the most aggressive treatment. They are those whose bodies retained the capacity to heal.
This distinction — between eliminating disease and preserving the conditions for recovery — is the central argument of this article. It is not an argument against conventional oncology. It is an argument for expanding what we consider treatment to include.
1. The Biological Truth Oncology Rarely States Explicitly
Medical science extends life and reduces suffering. But here is the foundational truth that gets underemphasized in clinical consultations: medical interventions create the conditions for recovery. They do not perform the recovery itself. The actual work of healing — cellular repair, immune surveillance, tissue regeneration, metabolic restoration — is done entirely by the patient’s body.
This is not alternative medicine philosophy. It is basic biology. When we look at the largest historical gains in human longevity, they did not come from complex hospital procedures. They came from nutrition, sanitation, and vaccines — all of which work by strengthening or supporting the body’s innate biological resilience rather than replacing it.
The centenarian populations studied in longevity research are not characterized by frequent medical intervention. They are characterized by low chronic stress, nutritional adequacy, physical activity, and social connection — the ecological conditions under which the human body’s self-repair systems function optimally. This is not coincidence. It is physiology.
2. Why Cancer Requires a Different Philosophical Framework
To understand why I advocate for what I call Natural Healing and Cancer Coexistence, we first need to be precise about what cancer actually is — because the dominant metaphors we use to describe it lead to treatment decisions that are sometimes counterproductive.
Cancer is not an invasion. Unlike bacteria or viruses, cancer cells are not foreign organisms. They are the patient’s own cells, operating outside the regulatory constraints that normally govern cell division and specialization. A single cancer cell is not inherently lethal. What makes cancer dangerous is the disruption of proportion and function: when undifferentiated cells multiply without restraint, they crowd out the specialized tissues that keep organs functioning.
In the framework of Korean medicine, health is defined by harmonious proportion — what we call homeostasis in Western terms, and what classical texts describe as the balance of Yin, Yang, and Qi. Cancer is, in this sense, a profound loss of proportion within the body’s own biological community. It does not poison the host from outside. It displaces the host’s functional biology from within.
This distinction matters clinically. If cancer is an internal disruption rather than an external enemy, then treatment strategies modeled on warfare — search and destroy, maximum tolerated dose, total eradication — may be solving the wrong problem. Or more precisely: they may be solving the right problem with tools that create a parallel problem.
3. The Paradox at the Core of Aggressive Oncology
I want to be careful here, because this point is frequently misunderstood. I am not arguing that chemotherapy or radiation is wrong. I am arguing that they present a genuine medical paradox that practitioners and patients need to understand clearly before making treatment decisions.
High-dose chemotherapy is highly effective at destroying rapidly dividing cells — including cancer cells. But many of the agents used are simultaneously classified as carcinogens. They damage healthy immune cells, suppress bone marrow function, and — critically — deplete the very natural healing capacity that determines whether a patient survives the treatment and recovers afterward.
The paradox is not theoretical. Clinically, we see it regularly: a patient completes a successful chemotherapy course, scans show tumor reduction, and yet the patient deteriorates. Their immune system is compromised. Their gut microbiome is disrupted. Their energy reserves are exhausted. They have survived the cancer protocol but lost the biological resilience needed to sustain that survival.
This is the core argument for coexistence over conquest: if the treatment systematically dismantles the body’s self-healing infrastructure, we may win the battle and lose the patient.
4. From Conquest to Coexistence: The Emerging Paradigm
The language of oncology is slowly changing. The rhetoric of “going to war” with cancer is giving way — in the research literature if not yet in clinical culture — to frameworks of management, chronicity, and sustainable control. This shift reflects real clinical and biological insight:
- Controlling rather than eradicating: The goal of eliminating every cancer cell often requires treatment intensities that destroy the patient’s quality of life and immune capacity. Managing tumor burden to a level that does not threaten vital organ function — while preserving the patient’s biological reserves — is increasingly recognized as a legitimate and often superior goal.
- Targeted and immunological approaches: Precision oncology and immunotherapy represent exactly this shift in practice. Rather than saturating the body with cytotoxic agents, these approaches attempt to engage the body’s own immune system or target cancer-specific molecular pathways while sparing healthy tissue.
- Host-centric care: The tumor microenvironment — the biological community surrounding a cancer — is now understood to be as important as the cancer cells themselves. A hostile microenvironment that supports immune surveillance can contain cancer. A depleted one cannot. Strengthening the host is not complementary to treatment; it is treatment.
From the perspective of Korean medicine, this convergence is not surprising. The classical principle that we treat the person, not the disease — 치인불치병(治人不治病) — has always prioritized systemic resilience over pathogen-specific elimination. Modern oncology is arriving at a similar conclusion through a different route.
5. What This Means for Patients: Practical Implications
The coexistence framework is not passive. It does not mean accepting cancer without treatment or abandoning evidence-based medicine. It means integrating two simultaneous objectives: addressing the tumor, and preserving the biological conditions that make recovery possible.
In my clinical experience, the patients who navigate this most effectively tend to share several characteristics:
- They treat sleep as a non-negotiable medical priority — not a luxury to sacrifice for treatment schedules.
- They maintain nutritional adequacy even during treatment, understanding that the body cannot repair itself without adequate substrate.
- They manage psychological stress actively, recognizing that chronic cortisol elevation suppresses immune function and accelerates tumor progression.
- They engage in gentle, consistent physical activity appropriate to their condition — not to “fight” cancer, but to maintain the metabolic and circulatory conditions that support immune function.
- They work with practitioners who view Korean medicine and conventional oncology as complementary rather than competing — using herbal support, acupuncture, and constitutional medicine to sustain the body’s resilience through aggressive treatment phases.
6. The Constitutional Dimension: Why Patients Respond Differently
One of the most clinically significant observations in integrative oncology is the enormous variability in treatment response and recovery. Two patients with identical diagnoses, stages, and treatment protocols can have radically different outcomes. Conventional medicine explains this partly through genetics and tumor biology. Korean medicine offers an additional layer: constitutional type.
The Eight Constitutional Medicine framework that I apply in clinical practice suggests that individuals differ fundamentally in their organ system hierarchy and energetic vulnerabilities. A Taeyang constitution and a Soeum constitution will respond differently to the same chemotherapy protocol — not just in side effects, but in their capacity to mobilize recovery. Identifying constitutional type allows for personalized supportive interventions that conventional oncology, by design, cannot provide.
This is not mysticism. It is pattern-based medicine with a centuries-long empirical foundation — one that modern precision medicine is beginning to approach from a genomic direction.
7. A Diagnosis Is Not a Verdict
The most important reframe I offer patients is this: a cancer diagnosis is information about the current state of your biological system. It is not a verdict about your future. The body that produced the cancer is the same body that contains the resources to manage it. Those resources can be depleted — by aggressive treatment, by chronic stress, by nutritional neglect — or they can be preserved and cultivated.
The patients I have watched recover with dignity and vitality are not those who fought hardest against their cancer. They are those who understood most clearly that healing and treatment are not the same thing — and who invested in both simultaneously.
Medicine provides the tools. The healing capacity resides within you. The task of good oncology — integrative or conventional — is to ensure that capacity is still intact when it is needed most.
This article reflects the clinical observations and ongoing research of Professor Seungho Baek, Professor of Korean Medicine at Dongguk University College of Korean Medicine, specializing in Pathology and Oncology.
